Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab

INTRODUCTION: Anti-VEGF treatment has proven effective in recurrent ovarian cancer. However, the identification of the patients most likely to respond is still pending. It is well known that the angiogenesis is regulated by several other pro-angiogenic proteins, e.g. the platelet - derived growth fa...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Madsen, Christine Vestergaard, Steffensen, Karina Dahl, Olsen, Dorte Aalund, Waldstrøm, Marianne, Smerdel, Maja, Adimi, Parvin, Brandslund, Ivan, Jakobsen, Anders
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2012
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3511256/
https://ncbi.nlm.nih.gov/pubmed/22989094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1757-2215-5-23
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi